In the present study, we confirm findings from other studies in the general population and cohorts of COVID-19 patients which have shown that plasma ACE2 levels increase with age, are higher in men, and in patients with hypertension, congestive heart failure, diabetes, obesity and cancer9,17. This evidence concerns the gene ACE2 and congestive heart failure.